Expression and molecular pharmacology of the mouse CRTH2 receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 306, Issue 2, 2003, Pages 463-470

  Hata, Aaron N ^a   Zent, Roy ^a,b   Breyer, Matthew D ^a,b   Breyer, Richard M ^a,b,c  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

^c VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

13,14 DIHYDRO 15 OXOPROSTAGLANDIN D2; 15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 5 (6 CARBOXYHEXYL) 1 (3 CYCLOHEXYL 3 HYDROXYPROPYL)HYDANTOIN; ACETYLSALICYLIC ACID; CRTH2 RECEPTOR; CYCLIC AMP; DP RECEPTOR; FLURBIPROFEN; G PROTEIN COUPLED RECEPTOR; IBUPROFEN; INDOMETACIN; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; NONSTEROID ANTIINFLAMMATORY AGENT; PARACETAMOL; PERTUSSIS TOXIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROSTAGLANDIN D2; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA; PROSTAGLANDIN J2; PROSTANOID; SALICYLATE SODIUM; SALICYLIC ACID; SULINDAC; UNCLASSIFIED DRUG; WORTMANNIN;

ALLERGIC DISEASE; ANIMAL CELL; ARTICLE; BASOPHIL; BINDING AFFINITY; BINDING COMPETITION; CHEMOTAXIS; CONTROLLED STUDY; EMBRYO; EOSINOPHIL; GENE EXPRESSION; HUMAN; HUMAN CELL; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; RADIOASSAY; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; HUMANS; LIGANDS; MICE; PROSTAGLANDIN D2; RADIOLIGAND ASSAY; RECEPTORS, IMMUNOLOGIC; RECEPTORS, PROSTAGLANDIN; SIGNAL TRANSDUCTION; TRITIUM;

EID: 0037622765     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.103.050955     Document Type: Article

References (40)

1. Abe H, Takeshita T, Nagata K, Arita T, Endo Y, Fujita T, Takayama H, Kubo M, and Sugamura K (1999) Molecular cloning, chromosome mapping and characterization of the mouse CRTH2 gene, a putative member of the leukocyte chemoattractant receptor family. Gene 227:71-77.
2. Barr RM, Koro O, Francis DM, Black AK, Numata T, and Greaves MW (1988) The release of prostaglandin D2 from human skin in vivo and in vitro during immediate allergic reactions. Br J Pharmacol 94:773-780.
3. Boie Y, Sawyer N, Slipetz DM, Metters KM, and Abramovitz M (1995) Molecular cloning and characterization of the human prostanoid DP receptor. J Biol Chem 270:18910-18916.
4. Cheng Y and Prusoff WH (1973) Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (150) of an enzymatic reaction. Biochem Pharmacol 22:3099-3108.
5. Cosmi L, Annunziato F, Galli MIG, Maggi RME, Nagata K, and Romagnani S (2000) CRTH2 is the most reliable marker for the detection of circulating human type 2 Th and type 2 T cytotoxic cells in health and disease. Eur J Immunol 30:2972-2979.
6. 2 attenuates the development of acute and chronic inflammation. Mol Pharmacol 61:997-1007.
7. Emery DL, Djokic TD, Graf PD, and Nadel JA (1989) Prostaglandin D2 causes accumulation of eosinophils in the lumen of the dog trachea. J Appl Physiol 67:959-962.
8. Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, and Young IG (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity and lung damage in a mouse asthma model. J Exp Med 183:195-201.
9. Fujitani Y, Kanaoka Y, Aritake K, Uodome N, Okazaki-Hatake K, and Urade Y (2002) Pronounced eosinophilic lung inflammation and Th2 cytokine release in human lipocalin-type prostaglandin D synthase transgenic mice. J Immunol 168: 443-449.
10. Gao JL, Lee EJ, and Murphy PM (1999) Impaired antibacterial host defense in mice lacking the N-formylpeptide receptor. J Exp Med 189:657-662.
11. Gervais FG, Cruz RP, Chateauneuf A, Gale S, Sawyer N, Nantel F, Metters KM, and O'Neill GP (2001) Selective modulation of chemokinesis, degranulation and apoptosis in eosinophils through the PGD2 receptors CRTH2 and DP. J Allergy Clin Immunol 108:982-988.
12. Giles H and Leff P (1988) The biology and pharmacology of PGD2. Prostaglandins 35:277-300.
13. Hardy CC, Robinson C, Tattersfield AE, and Holgate ST (1984) The bronchoconstrictor effect of inhaled prostaglandin D2 in normal and asthmatic men. N Engl J Med 311:209-213.
14. 12,14-PGJ2 induces IL-8 production in human T cells by a mitogen-activated protein kinase pathway. J Immunol 168:1372-1379.
15. 2 receptor, CRTH2. J Immunol 168:981-985.
16. Hirai H, Tanaka K, Yoshie O, Ogawa K, Kenmotsu K, Takamori Y, Ichimasa M, Sugamura K, Nakamura M, Takano S, and Nagata K (2001) Prostaglandin D2 selectively induces chemotaxis in T helper type 2 cells, eosinophils and basophils via seven-transmembrane receptor CRTH2. J Exp Med 193:255-261.
17. Hirata M, Kakizuka A, Aizawa M, Ushikubi F, and Narumiya S (1994) Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene. Proc Natl Acad Sci USA 91:11192-11196.
18. Hirsch E, Katanaev VL, Garlanda C, Azzolino O, Pirola L, Silengo L, Sozzani S, Mantovani A, Altruda F, and Wymann MP (2000) Central role for G protein-coupled phosphoinositide 3-kinase γ in inflammation. Science (Wash DC) 287: 1049-1053.
19. Kliewer SA, Lenhard JM, Willson TM, Patel I, Morris DC, and Lehmann JM (1995) A prostaglandin J2 metabolite binds peroxisome proliferator-activated receptor gamma and promotes adipocyte differentiation. Cell 83:813-819.
20. Lehmann JM, Lenhard JM, Oliver BB, Ringold GM, and Kliewer SA (1997) Peroxisome proliferator-activated receptors alpha and gamma are activated by indomethacin and other nonsteroidal anti-inflammatory drugs. J Biol Chem 272:3406-3410.
21. 2 and the thiazolidinedione ciglitazone through peroxisome proliferator activator receptor £-independent mechanisms involving reactive oxygenated species. J Biol Chem 277:29681-29685.
22. Lewis RA, Soter NA, Diamond PT, Austen KF, Oates JA, and Roberts LJ 2nd (1982) Prostaglandin D2 generation after activation of rat and human mast cells with anti-IgE. J Immunol 129:1627-1631.
23. Mathew A, Medoff BD, Carafone AD, and Luster AD (2002) Cutting edge: Th2 cell trafficking into the allergic lung is dependent on chemoattractant receptor signaling. J Immunol 169:651-655.
24. Matsuoka T, Hirata M, Tanaka H, Takahashi Y, Murata T, Kabashima K, Sugimoto Y, Kobayashi T, Ushikubi F, Aze Y, et al. (2000) Prostaglandin D2 as a mediator of allergic asthma. Science (Wash DC) 287:2013-2017.
25. Meili R, Ellsworth C, Lee S, Reddy TB, Ma H, and Firtel RA (1999) Chemoattractant-mediated transient activation and membrane localization of Akt/PKB is required for efficient chemotaxis to cAMP in Dictyostelium. EMBO (Eur Mol Biol Organ) J 18:2092-2105.
26. Mitchell JA, Akarasereenont P, Thiemermann C, Flower RJ, and Vane JR (1993) Selectivity of nonsteroidal antiinflammatory drugs as inhibitors of constitutive and inducible cyclooxygenase. Proc Natl Acad Sci USA 90:11693-11697.
27. 12,14 prostaglandins D2 and J2 are potent activators of human eosinophils. J Immunol 168:3563-3569.
28. Morrow JD and Roberts LJ (2001) Lipid-Derived Autocoids, in Goodman & Gilmans's The Pharmacological Basis of Therapeutics (Hardman JG and Limbird LE eds) pp 669-685, McGraw Hill, New York.
29. Murray JJ, Tonnel AB, Brash AR, Roberts LJ 2nd, Gosset P, Workman R, Capron A, and Oates JA (1986) Release of prostaglandin D2 into human airways during acute antigen challenge. N Engl J Med 315:800-804.
30. Nagata K, Hirai H, Tanaka K, Ogawa K, Aso T, Sugamura K, Nakamura M, and Takano S (1999) CRTH2, an orphan receptor of T-helper-2-cells, is expressed on basophils and eosinophils and responds to mast cell-derived factor(s). FEBS Lett 459:195-199.
31. s. Proc Natl Acad Sci USA 94:14489-14494.
32. Niggli V and Keller H (1997) The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils. Eur J Pharmacol 335:43-52.
33. 2+ mobilization, Ras-mitogen-activated protein kinase activation and adenylate cyclase inhibition. J Biol Chem 273:27104-27110.
34. Pellas TC, Boyar W, van Oostrum J, Wasvary J, Fryer LR, Pastor G, Sills M, Braunwalder A, Yarwood DR, Kramer R, et al. (1998) Novel C5a receptor antagonists regulate neutrophil functions in vitro and in vivo. J Immunol 160:5616-5621.
35. 2 receptor, CRTH2. Br J Pharmacol 137:1163-1172.
36. 12,14-prostaglandin J2. A prostaglandin D2 metabolite generated during inflammatory processes. J Biol Chem 277:10459-10466.
37. 2-like and eotaxin-like selective responses in eosinophils and basophils. J Biol Chem 277:26012-26020.
38. i-coupled receptor Edg-1 and intracellular to regulate proliferation and survival. J Cell Biol 142:229-240.
39. Ward C, Dransfield I, Murray J, Farrow SN, Haslett C, and Rossi AG (2002) Prostaglandin D2 and its metabolites induce caspase-dependent granulocyte apoptosis that is mediated via inhibition of I‰B$ degradation using a peroxisome proliferator-activated receptor-£-independent mechanism. J Immunol 168:6232-6243.
40. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, and Donaldson DD (1998) Interleukin-13: central mediator of allergic asthma. Science (Wash DC) 282:2258-2261.